Navigation Links
Drug Advertising needs to be Limited

The American Medical Association has called for moratoriums on consumer advertising which promotes new drugs and medical devices until it is shown that the products// are safe and that they work.

The American Medical Association, U.S. largest physicians' group has urged the U.S. Food and Drug Administration to instruct manufacturers to complete an unspecified waiting period after a drug or device obtains regulatory approval before direct-to-consumer advertising is launched on television, in print, or elsewhere.

Although the doctors' groups have considered a years-long moratorium, they decided to let the FDA set the time span, depending on whether the drug or device breaks new ground.

According to physicians several patients demand inappropriate drugs after being exposed to a drug company's advertisement. Drug makers have said the ads educate the public and only advise patients to ask their doctors.

The house of delegates of the AMA which set the group's policy at its annual meeting has recommended that the FDA pre-approve such advertisements, ensuring that they are based on objective information from clinical trials that would reveal the balance between a product's benefits and risks, as well as define warnings and potential adverse reactions properly.

The AMA's president-elect, Dr. Ronald Davis said, 'Physicians will have the opportunity to become better educated on the pros and cons of prescription drug uses before prescribing them, and will be better able to determine when they are best suited for their patients' medical needs.'

A drug industry group has said that it shared the AMA's goal of educating the public which was proved by last year's agreement among manufacturers to voluntarily inform the health-care community before launching consumer ads.

Dr. Paul Antony of the Pharmaceutical Research and Manufacturers of America said, 'The length of time this requires will vary from medicine to medicine, and companies will likely meet this goal in different ways.'

High-profile drugs like Vioxx was withdrawn by Merck in 2004 following the development of problematic side affects like an increase in heart attacks and strokes. Vioxx was popularized because of its huge advertising budget.

AMA' s decision came following argument by some plaintiffs in lawsuits that Merck continued to promote the painkiller despite knowledge that it carried risks.


'"/>




Related medicine news :

1. Anti-tobacco Advertising Can Reduces smoking Among Teens
2. New Rule Results In The Complete Makeover In The Field Of Drug Advertising
3. Subliminal Advertising works
4. Pfizer Commences Its Advertising for Celebrex with All the Warnings
5. Tobacco Advertising Through Movies Luring Kids
6. Advertising Blamed For Kids Poor Choices
7. CDC Uses Advertising Campaign to Get Kids Moving
8. Synova Acquires Rights to Today Sponge Contraceptive, Plans Advertising Campaign
9. Body mass index guide needs revision
10. Risk of heart disease prediction needs updating
11. Air pollution combined with greater medical needs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia ... the company,s second affiliate in Latin America . ... ... Farma Colombia ... ...
(Date:6/23/2016)... Tenn. , June 23, 2016 /PRNewswire/ ... automating, integrating and transforming the patient payment ... of several innovative new products and services ... of its revenue cycle offerings. These award-winning ... more efficient workflows, remain compliant in an ...
Breaking Medicine Technology: